Common Contracts
6 similar Underwriting Agreement contracts by Aileron Therapeutics Inc, Allogene Therapeutics, Inc., Brookdale Senior Living Inc., others
Allogene Therapeutics, Inc. Common Stock Underwriting AgreementUnderwriting Agreement • May 14th, 2024 • Allogene Therapeutics, Inc. • Biological products, (no disgnostic substances)
Allogene Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this agreement (this “Agreement”), to issue and sell to Goldman Sachs & Co. LLC (the “Underwriter”) an aggregate of 36,896,551 shares of the Company’s common stock, par value $0.001 per share (“Stock”, and such shares, the “Shares”).
Dated March , 2023Underwriting Agreement • March 27th, 2023 • Himalaya Shipping Ltd. • Deep sea foreign transportation of freight
Himalaya Shipping Ltd. (the “Company”) announced today that DNB Markets, Inc., the sole global coordinator, joint bookrunner and representative of the underwriters in the recent public sale of common shares of the Company, is [waiving] [releasing] a lock-up restriction with respect to common shares held by [certain officers or directors] [an officer or director] of the Company. The [waiver] [release] will take effect on , 20 , and the shares may be sold on or after such date.
Catalent, Inc. Common Stock, par value $0.01 per share Underwriting AgreementUnderwriting Agreement • June 15th, 2020 • Catalent, Inc. • Pharmaceutical preparations • New York
Catalent, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated in this underwriting agreement (this “Agreement”), to issue and sell to RBC Capital Markets, LLC (the “Underwriter”), an aggregate of 8,912,500 shares of common stock, par value $0.01 per share (the “Stock”), of the Company. The aggregate of 7,750,000 shares of Stock to be sold by the Company are herein called the “Firm Shares” and the aggregate of up to 1,162,500 additional shares of Stock to be sold by the Company are herein called the “Optional Shares.” The Firm Shares and the Optional Shares that the Underwriter elects to purchase pursuant to Section 2 hereof are herein collectively called the “Shares.” The terms “supplement,” “amendment” and “amend” as used herein with respect to the Registration Statement, the Preliminary Prospectus, the Prospectus or the Pricing Prospectus (each as defined below) shall include all documents subsequently filed by the Company with the Secur
AILERON THERAPEUTICS, INC. Common Stock, par value $0.001 per share Underwriting AgreementUnderwriting Agreement • June 5th, 2020 • Aileron Therapeutics Inc • Pharmaceutical preparations • New York
Aileron Therapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the Underwriters named in Schedule I hereto (the “Underwriters”) for whom William Blair & Company, L.L.C. is acting as representative (the “Representative” or “you”) an aggregate of 9,090,910 shares (the “Firm Securities”) and, at the election of the Underwriters, up to 1,363,636 additional shares (the “Optional Securities”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriters elect to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”). To the extent that you are the only Underwriter, all references to “each Underwriter,” “the Underwriters” or “Representative” shall refer to just you.
ENSERVCO CORPORATION Common Stock, par value $0.005 per share Underwriting AgreementUnderwriting Agreement • December 7th, 2016 • Enservco Corp • Oil & gas field services, nec • New York
Enservco Corporation, a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to William Blair & Company, L.L.C. (the “Underwriter” or “you”) an aggregate of 11,250,000 shares (the “Firm Securities”) and, at the election of the Underwriter, up to 1,687,500 additional shares (the “Optional Securities”) of common stock, par value $0.005 per share (the “Common Stock”), of the Company (the Firm Securities and the Optional Securities that the Underwriter elects to purchase pursuant to Section 2 hereof are herein collectively called the “Securities”).
BROOKDALE SENIOR LIVING INC. COMMON STOCK UNDERWRITING AGREEMENTUnderwriting Agreement • September 12th, 2014 • Brookdale Senior Living Inc. • Services-nursing & personal care facilities • New York
Brookdale Senior Living Inc., a Delaware corporation (the “Company”) proposes, subject to the terms and conditions set forth herein, to sell to the underwriters listed on Schedule I hereto (the “Underwriters”) for whom you are acting as representatives (the “Representatives”) an aggregate of 8,955,223 shares (the “Initial Shares”) of common stock, par value $0.01 per share, of the Company (“Common Stock”) and at the option of the Underwriters, up to an additional 1,343,283 shares of common stock (the “Option Shares” and, together with the Initial Shares, the “Shares”).
